Eboni Funderburk
FDA investigator
Appears on 2 documents from 2021 to 2022, mostly at sites in Indiana. Most often cites written procedures; deviations (21 CFR 211.100(a)).
- 2
- Documents on file
- 5.5
- Observations per 483
- 2021
- First seen
- 2022
- Most recent
What they cite most
From 10 observations- 21 CFR 211.100(a)Written procedures; deviations2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.125(a)Labeling issuance1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.192Production record review1
Activity by year
2021: 1, 2022: 1
Where
Indiana 1 · Kentucky 1
Often inspects with
Is Eboni Funderburk coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-09-01 | 483 Catalent Indiana, LLCSep 1, 2022 · Bloomington, Indiana | Bloomington, Indiana | 6 | |
| 2021-08-31 | 483 Ceela NaturalsAug 31, 2021 · Louisville, Kentucky | Louisville, Kentucky | 5 |
About this profile
What does Eboni Funderburk inspect?
Eboni Funderburk appears on 2 documents on file covering 1 site, mostly in Indiana.
What do they cite most often?
21 CFR 211.100(a) (written procedures; deviations), followed by 21 CFR 211.110 and 21 CFR 211.113.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Eboni Funderburk is dated Sep 1, 2022.